Pineapple Express Cannabis (PNXP) Non Operating Investment Income (2023)

Pineapple Express Cannabis' (PNXP) quarterly Non Operating Investment Income came in at $143276.0 in Q4 2023, down 77.37% quarter-over-quarter from $633160.0 in Q3 2023.

Pineapple Express Cannabis (PNXP) Non Operating Investment Income (2023) Analysis & Trends

Pineapple Express Cannabis has disclosed Non Operating Investment Income across 1 years of filings, most recently posting $143276.0 for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 Pineapple Express Cannabis - - - -

Historic Data

Download Data
DateValue
Oct 31, 2023 143,276.00
Oct 31, 2023 143,276.00
Jul 31, 2023 633,160.00
Jul 31, 2023 633,160.00
Apr 30, 2023 209,300.00
Apr 30, 2023 209,300.00